This kit is used for genotyping human ADRB1 gene c.1165 from genomic DNA extracted from patients' peripheral blood. The ADRB1 c.1165 polymorphism influences the drug response to β-blocker therapy. The test results of can provide guidance for personalized clinical treatment.
Product Advantages
1、Recommended by the clinical guidelines
2、High accuracy: having a unique internal reference design
3、Easy to use and fast turn-around
2、High accuracy: having a unique internal reference design
3、Easy to use and fast turn-around
Target group
1、Heart failure patients
2、Patients with coronary artery disease
3、Patients with cardiac arrhythmia
4、Patients with cardiomyopathy
5、Patients with hypertension
6、Patients with cardiac surgery, etc.
2、Patients with coronary artery disease
3、Patients with cardiac arrhythmia
4、Patients with cardiomyopathy
5、Patients with hypertension
6、Patients with cardiac surgery, etc.
